anticonvulsant/headache

BACKGROUND OF THE INVENTION Compounds of Formula I: ##STR1## are structurally novel antiepileptic compounds that are highly effective anticonvulsants in animal tests (Maryanoff, B. E, Nortey, S. O., Gardocki, J. F., Shank, R. P. and Dodgson, S. P. J Med. Chem. 30, 880-887, 1987; Maryanoff, B. E.,

TECHNICAL FIELD Embodiments disclosed herein generally relate to a method of treatment for weight-loss and other conditions in a mammal. More particularly, embodiments herein are directed to anatomically targeted, low-dosage delivery of antiepileptic/anticonvulsant compounds for weight-loss and

FIELD OF THE INVENTION The present invention is directed to the novel uses of a peptide class of compounds for treating bipolar disorders and headaches, such as migraines and pain, especially neuropathic pain. BACKGROUND OF THE INVENTION Bipolar disorders and headaches, such as migraines, and pain,

FIELD OF THE INVENTION The present invention is directed to the novel uses of a peptide class of compounds for treating bipolar disorders and headaches, such as migraines and pain, especially neuropathic pain. BACKGROUND OF THE INVENTION Bipolar disorders and headaches, such as migraines, and pain,

FIELD OF THE INVENTION The present invention is directed to the novel uses of a peptide class of compounds for treating bipolar disorders and headaches, such as migraines and pain, especially neuropathic pain. BACKGROUND OF THE INVENTION Bipolar disorders and headaches, such as migraines, and pain,

FIELD OF THE INVENTION The present invention is directed to the novel uses of a peptide class of compounds for treating bipolar disorders and headaches, such as migraines and pain, especially neuropathic pain. BACKGROUND OF THE INVENTION Bipolar disorders and headaches, such as migraines, and pain,

BACKGROUND OF THE INVENTION 1. The Field of the Invention The present invention relates to novel compounds showing activity in the central nervous systems (CNS). More specifically, the present invention relates to novel compounds with anticonvulsant activity that exhibit increased/improved

BACKGROUND OF THE INVENTION 1. The Field of the Invention The present invention relates to novel compounds showing activity in the central nervous systems (CNS) of experimental animals. More specifically, the present invention relates to novel compounds with anticonvulsant activity that exhibit